WP1: Organization and governance Chair Kjeld Schmiegelow, co-chair Henrik Hasle
Work Packages
WP2: Cancer predisposition Chair Karin Wadt, co-chair Kjeld Schmiegelow
WP3: Cancer surveillance and earlier diagnosis Chair Kjeld Schmiegelow, co-chair Rene Mathiasen
WP4: Cancer geomics and biology Chair Jesper Brok, co-chair Olga Østrup
WP5: CNS tumors and CNS metastasis Chair Rene Mathiasen, co-chair Petra Hamerlik
WP6: Treatment response Chair Hanne Marquart, co-chair Lisa Hjalgrim
WP7: Pharmacology Chair Kjeld Schmiegelow, co-chair Kim Dalhoff
WP8: Immune therapy Chair Klaus Müller, co-chair Inge Marie Svane
WP9: Phase 1 & 2 trials Chair Karsten Nysom, co-chair Krister Wennerberg
WP10: Acute toxicities Chair Kjeld Schmiegelow, co-chair Thomas Frandsen
WP11: Late effects Chair Christoffer Johansen, co-chair Henrik Hasle
WP12: Palliation Chair Marianne Olsen, co-chair Mette Asbjørn Neergaard
WP13: Social inequality Chair Hanne Bækgaard, co-chair Susanne Dalton
WP14: Play and activity Chair Hanne Bækgaard, co-chair Thomas Frandsen
WP15: Warehouse Chair Henrik Hjalgrim, co-chair Jens Lundgren
WP16: Biostatistical Modeling Chair Kathrine Grell, co-chair Kjeld Schmiegelow
WP17: Ethics Chair Ayo Wahlberg, co-chair Anne-Marie Gerdes